send to a friend by email
2015-02-15
According to Birzeit Pharmaceuticals Company BPC’s consolidated data for year-end preliminary financial statements for year 2014, net profit after tax reached 4,609,475 USD, compared with a net profit after tax of 5,480,204 USD in the audited data for 2013, a net decrease of 15.9%. Total assets of the company reached 70,163,852 USD as of December 31st, 2014, compared to total assets of 64,753,100 USD as of December 31st, 2013, a net increase of 8.4%. Total liabilities of the company reached 16,509,344 USD as of December 31st, 2014, compared to total liabilities of 12,828,330 USD as of December 31st, 2013, a net increase of 28.7%. Net ownership equity of the company reached 53,654,508 USD (including 269,277 USD in Non-controlling interest) as of December 31st, 2014, compared with a net ownership equity of 51,924,770 USD (including 199,413 USD in Non-controlling interest) as of December 31st, 2013, a net increase of 3.3%.
|
|